Precautionary period for the safe handling of excreta or body fluids in patients receiving cytotoxic or antineoplastic therapy: clinical evidence and guidelines
CADTH
Record ID 32014000157
English
Authors' recommendations:
No relevant health technology assessments, systematic reviews, meta-analyses, or evidence-based guidelines were identified regarding the timeframe of the precautionary period for patients receiving cytotoxic or antineoplastic therapy, with regard to the safe handling of excreta, blood products, or other bodily fluids.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
http://www.cadth.ca/media/pdf/htis/jun-2013/RB0584%20Cytotoxic%20precautionary%20period%20Final.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Cytotoxicity, Immunologic
- Feces
- Hazardous Waste
- Specimen Handling
- Time Factors
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.